ADA 2023 Insights
ADA 2023 Insights: The Effect of Tirzepatide Versus Insulin Degludec on Post Meal Glucose Control in Patients with Type 2 Diabetes (SURPASS-3 CGM)
By
ADA 2023 Insights
FEATURING
Tadej Battelino
By
ADA 2023 Insights
FEATURING
Tadej Battelino
Comments 3
Login to view comments.
Click here to Login